Loading...

Loading...

COFEPRIS’s New Molecules Registry Updated
By Miriam Bello - Tue, 06/29/2021 - 12:53
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
https://mexicobusiness.news/tag/chiesi
More Health
Chiesi: Less Invasive Tech Defeats Old Enemy
By - Fri, 09/20/2019 - 10:11
Respiratory Distress Syndrome is a breathing disorder that affects mainly premature infants, which leads to breathing problems and often deficiency of pulmonary surfactant that does not permit the expansion of the alveoli for proper gas exchange.
Focus Should Be on Total Treatment Cost Not Drug Cost
By - Wed, 06/05/2019 - 18:30
Chiesi Group is a pharmaceutical manufacturer founded in Italy in 1935.
Innovative Technologies for Better Therapeutic Solutions
By - Wed, 09/05/2018 - 13:53
People suffering from respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD) will benefit
Family-Owned Pharma’s Drug Formulation a Difference Maker
By - Wed, 09/05/2018 - 12:11
Chiesi Farmaceutici is a pharmaceutical company based in Italy and founded in 1935.